Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02537314Phase 1Completed
Phase 1 trial of benzocaine in obesity (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Gastrointestinal Hormones at 5 Hours, Pancreatic Hormones at 5 Hours and 1 more. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02537314.